{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:18:46Z","timestamp":1790983126714,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,10]]},"DOI":"10.7759\/cureus.112392","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T11:07:52Z","timestamp":1783681672000},"source":"Crossref","is-referenced-by-count":1,"title":["Analysis of Seriousness and Preventability of Adverse Drug Reactions in Patients at a Tertiary Care Teaching Hospital: A Case Series"],"prefix":"10.7759","author":[{"given":"Raja Vikram","family":"Prasad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshay Kumar","family":"V","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivekanandan","family":"Kalaiselvan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Deepalatha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaishree","family":"Suresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Kodali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreya","family":"Nallapati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Jyoshna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/MS9.0000000000002625","article-title":"A young female's battle with toxic epidermal necrolysis induced by NSAIDs: A case report","volume":"86","author":"Adhikari P","year":"2024","unstructured":"Adhikari P, Singh U, Yadav PS, Shah L, Dev A, Mandal SC. A young female's battle with toxic epidermal necrolysis induced by NSAIDs: A case report. Ann Med Surg (Lond). 2024, 86:6869-73. 10.1097\/MS9.0000000000002625","journal-title":"Ann Med Surg (Lond)"},{"key":"ref2","article-title":"Preventability and severity assessment in reporting adverse drug reactions","volume":"49","author":"Hartwig SC","year":"1992","unstructured":"Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm. 1992, 49:2229-32.","journal-title":"Am J Hosp Pharm"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/anae.14143","article-title":"Adverse drug reactions","volume":"73 Suppl 1","author":"Patton K","year":"2018","unstructured":"Patton K, Borshoff DC. Adverse drug reactions. Anaesthesia. 2018, 73 Suppl 1:76-84. 10.1111\/anae.14143","journal-title":"Anaesthesia"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02799-9","article-title":"Adverse drug reactions: Definitions, diagnosis, and management","volume":"356","author":"Edwards IR","year":"2000","unstructured":"Edwards IR, Aronson JK. Adverse drug reactions: Definitions, diagnosis, and management. Lancet. 2000, 356:1255-9. 10.1016\/S0140-6736(00)02799-9","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.16-1-79","article-title":"Severe adverse drug reactions","volume":"16","author":"Teo YX","year":"2016","unstructured":"Teo YX, Walsh SA. Severe adverse drug reactions. Clin Med (Lond). 2016, 16:79-83. 10.7861\/clinmedicine.16-1-79","journal-title":"Clin Med (Lond)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.aichem.2023.100011","article-title":"Application of artificial intelligence and machine learning in early detection of adverse drug reactions (ADRs) and drug-induced toxicity","volume":"1","author":"Yang S","year":"2023","unstructured":"Yang S, Kar S. Application of artificial intelligence and machine learning in early detection of adverse drug reactions (ADRs) and drug-induced toxicity. Artif Intell Chem. 2023, 1:100011. 10.1016\/j.aichem.2023.100011","journal-title":"Artif Intell Chem"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222413302","article-title":"Genophenotypic factors and pharmacogenomics in adverse drug reactions","volume":"22","author":"Cacabelos R","year":"2021","unstructured":"Cacabelos R, Naidoo V, Corzo L, Cacabelos N, Carril JC. Genophenotypic factors and pharmacogenomics in adverse drug reactions. Int J Mol Sci. 2021, 22:13302. 10.3390\/ijms222413302","journal-title":"Int J Mol Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4103\/0253-7613.194855","article-title":"Pharmacovigilance Programme of India: Recent developments and future perspectives","volume":"48","author":"Kalaiselvan V","year":"2016","unstructured":"Kalaiselvan V, Thota P, Singh GN. Pharmacovigilance Programme of India: Recent developments and future perspectives. Indian J Pharmacol. 2016, 48:624-8. 10.4103\/0253-7613.194855","journal-title":"Indian J Pharmacol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/00185787221145110","article-title":"Evaluation of detected medication errors within the operating room at an academic medical center","volume":"58","author":"Wolf M Jr","year":"2023","unstructured":"Wolf M Jr, Rolf J, Nelson D, Smith D, Hess E. Evaluation of detected medication errors within the operating room at an academic medical center. Hosp Pharm. 2023, 58:309-14. 10.1177\/00185787221145110","journal-title":"Hosp Pharm"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.5455\/njppp.2022.12.11416202126112021","article-title":"Analysis of drug use in patients of analgesic nephropathy","author":"Grover IS","year":"2021","unstructured":"Grover IS, Deepak C, Prasad RK, Satyagama S. Analysis of drug use in patients of analgesic nephropathy. Natl J Physiol Pharm Pharmacol. 2021, 10.5455\/njppp.2022.12.11416202126112021","journal-title":"Natl J Physiol Pharm Pharmacol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.3145","article-title":"Analysis of severity and preventability in patients of-Toxic epidermal necrolysis-A case series","volume":"8","author":"Ciddhavaduta DL","year":"2020","unstructured":"Ciddhavaduta DL, Kalaiselvan V, Midde ML, Baloju D. Analysis of severity and preventability in patients of-Toxic epidermal necrolysis-A case series. Clin Case Rep. 2020, 8:2452-6. 10.1002\/ccr3.3145","journal-title":"Clin Case Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-019-4651-7","article-title":"Adverse drug reactions in primary care: A scoping review","volume":"20","author":"Khalil H","year":"2020","unstructured":"Khalil H, Huang C. Adverse drug reactions in primary care: A scoping review. BMC Health Serv Res. 2020, 20:5. 10.1186\/s12913-019-4651-7","journal-title":"BMC Health Serv Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.329.7456.15","article-title":"Adverse drug reactions as cause of admission to hospital: Prospective analysis of 18 820 patients","volume":"329","author":"Pirmohamed M","year":"2004","unstructured":"Pirmohamed M, James S, Meakin S, et al.. Adverse drug reactions as cause of admission to hospital: Prospective analysis of 18 820 patients. BMJ. 2004, 329:15-9. 10.1136\/bmj.329.7456.15","journal-title":"BMJ"},{"key":"ref14","unstructured":"The Use of the WHO-UMC System for Standardised Case Causality Assessment. Uppsala Monitoring Centre. (2026). Accessed. July 7, 2026: https:\/\/who-umc.org\/media\/u4gjgxvv\/who-umc-causality-assessment_new-logo.pdf."},{"key":"ref15","article-title":"Focusing on the preventability of adverse drug reactions","volume":"27","author":"Schumock GT","year":"1992","unstructured":"Schumock GT, Thornton JP. Focusing on the preventability of adverse drug reactions. Hosp Pharm. 1992, 27:538.","journal-title":"Hosp Pharm"},{"key":"ref16","unstructured":"VigiLyze Data Mining Tool. Uppsala Monitoring Centre. (2026). Accessed. May 1, 2026: https:\/\/vigilyze.who-umc.org\/."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0205426","article-title":"Incidence, causes, and consequences of preventable adverse drug reactions occurring in inpatients: A systematic review of systematic reviews","volume":"13","author":"Wolfe D","year":"2018","unstructured":"Wolfe D, Yazdi F, Kanji S, et al.. Incidence, causes, and consequences of preventable adverse drug reactions occurring in inpatients: A systematic review of systematic reviews. PLoS One. 2018, 13:e0205426. 10.1371\/journal.pone.0205426","journal-title":"PLoS One"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0252161","article-title":"Prevalence of adverse drug reactions in the primary care setting: A systematic review and meta-analysis","volume":"16","author":"Insani WN","year":"2021","unstructured":"Insani WN, Whittlesea C, Alwafi H, Man KK, Chapman S, Wei L. Prevalence of adverse drug reactions in the primary care setting: A systematic review and meta-analysis. PLoS One. 2021, 16:e0252161. 10.1371\/journal.pone.0252161","journal-title":"PLoS One"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200831010-00003","article-title":"Methods for causality assessment of adverse drug reactions: A systematic review","volume":"31","author":"Agbabiaka TB","year":"2008","unstructured":"Agbabiaka TB, Savovi\u0107 J, Ernst E. Methods for causality assessment of adverse drug reactions: A systematic review. Drug Saf. 2008, 31:21-37. 10.2165\/00002018-200831010-00003","journal-title":"Drug Saf"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.rcsop.2025.100579","article-title":"Probing the in-depth analysis of serious adverse drug reactions in a tertiary care hospital of Central India","volume":"17","author":"Singh P","year":"2025","unstructured":"Singh P, Verma S, Vaishnav Y, Joshi U, Agrawal M. Probing the in-depth analysis of serious adverse drug reactions in a tertiary care hospital of Central India. Explor Res Clin Soc Pharm. 2025, 17:100579. 10.1016\/j.rcsop.2025.100579","journal-title":"Explor Res Clin Soc Pharm"},{"key":"ref21","unstructured":"Pharmacovigilance Programme of India. Performance Report 2023-24. Indian Pharmacopoeia Commission, Ministry of Health and Family Welfare, Government of India. Accessed: December 1, 2025: https:\/\/www.ipc.gov.in\/images\/Annual_Performance_Report_of_PvPI_2023-2024.pdf."},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.18231\/j.ijcaap.2024.007","article-title":"Management of adverse drug reactions: A review","volume":"9","author":"Aate J","year":"2024","unstructured":"Aate J. Management of adverse drug reactions: A review. IP Int J Compr Adv Pharmacol. 2024, 9:45-51. 10.18231\/j.ijcaap.2024.007","journal-title":"IP Int J Compr Adv Pharmacol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/463739-analysis-of-seriousness-and-preventability-of-adverse-drug-reactions-in-patients-at-a-tertiary-care-teaching-hospital-a-case-series","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T11:07:53Z","timestamp":1783681673000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/463739-analysis-of-seriousness-and-preventability-of-adverse-drug-reactions-in-patients-at-a-tertiary-care-teaching-hospital-a-case-series"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.112392","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,10]]}}}